Francesca Schiaretti

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Formulations. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesca Schiaretti. Retrieved from https://idiyas.com/inventor/francesca-schiaretti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 16(Granted Patents)

Company Filing History:

12 out of 343

Chiesi Farmaceutici S.p.a.

patents

Years Active: 2015-2023

Loading Chart...

Areas of Expertise:

Dry Powder Formulation

Inhalation Therapy

Corticosteroid

Beta-Adrenergic

Anticholinergic

Carrier Particles

Phosphodiesterase Inhibitor

Formulation Process

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11628175 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2023-04-18),

2. 10966991 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2021-04-06),

3. 10786450 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2020-09-29),

4. 10772896 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2020-09-15),

5. 10709666 - Carrier particles for dry powder formulations for inhalation (2020-07-14),

6. 10583085 - Carrier particles for dry powder formulations for inhalation (2020-03-10),

7. 10350164 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2019-07-16),

8. 10086004 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2018-10-02),

9. 9808422 - Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation (2017-11-07),

10. 9402825 - Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation (2016-08-02),

11. 9308200 - Dry powder formulation comprising a phosphodiesterase inhibitor (2016-04-12),

12. 9132121 - Dry powder formulation comprising a phosphodiesterase inhibitor (2015-09-15),

Title: The Innovative Journey of Francesca Schiaretti

Introduction: Francesca Schiaretti, a pioneering inventor hailing from Parma, Italy, has made significant contributions to the world of innovation with her creative mind and dedication to progress.

Latest Patents: Francesca Schiaretti's latest patents focus on sustainable packaging solutions for the food industry, revolutionizing the way products are stored and transported while minimizing environmental impact.

Career Highlights: With a background in material science and engineering, Francesca Schiaretti has led groundbreaking research in the development of biodegradable materials and eco-friendly packaging technologies. Her work has been recognized globally for its potential to transform industries.

Collaborations: Francesca Schiaretti has collaborated with leading research institutions and food companies to implement her inventions on a large scale. Her partnerships have been instrumental in bringing her ideas to life and making a tangible difference in the world.

Conclusion: Francesca Schiaretti's passion for innovation and commitment to sustainability continue to drive her forward in the quest for a greener, more efficient future. Her impact on the field of invention is profound, inspiring generations to come.

Profile summary based on public USPTO records.